Labelling and Clinical Performance of Human Leukocytes Labelled with <sup>99m</sup>Tc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent

<div>Trypan blue exclusion test of WBCs showing very high cell viability after erythrocyte sedimentation with HES, Gelofusine, or control solution. Each square represents a random field from 5 different subjects (A, B, C, D, and E).</div>

Contrast Media & Molecular Imaging

fig3

Figure 3

Figure 3: Labelling and Clinical Performance of Human Leukocytes Labelled with <sup>99m</sup>Tc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent 

Figure 3 | Labelling and Clinical Performance of Human Leukocytes Labelled with 99mTc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent 